Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter's five force analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Adoption of gene therapy
4.1.2 Increase in chronic diseases
4.1.3 Improvements in big data analytics
4.2 Restraints
4.2.1 Cost of personalised medicine
4.2.2 Misinterpretation of genetic data
4.3 Opportunities
4.3.1 New therapeutic targets
4.3.2 Understanding of how cancer defect immune system.
4.4 Challenges
4.4.1.Advancement of pharmacogenomics
Chapter 5 Europe Precision Market – By Type of Technology
5.1 Bioinformatics
5.2 Gene Sequencing
5.3 Big Data Analytics
5.4 Companion Diagnostics
5.5 Drug Discovery
Chapter 6 Europe Precision Market - By Application
6.1 Immunology
6.2 Respiratory
6.3 Neurology
6.4 CNS
6.5 Oncology
Chapter 7 Europe Precision Market - By Geography
7.1 Introduction
7.2Europe
7.2.1. U.K.
7.2.2. Germany
7.2.3. France
7.2.4. Italy
7.2.5. Spain
7.2.6. Rest of Europe
Chapter 8 Europe Precision Market - Company Profiles
8.1. Covance Inc.
8.2.Ferrer InCode
8.3Novartis Holding AG.
8.4.QIAGEN Inc.
8.5. Teva Pharmaceutical
8.6. Medtronic
8.7.Nanostring Technologies
8.8.Eagle Genomics
8.9.Silicon Biosystems
8.10.Pfizer
8.11.Roche Diagnostics
8.12.Intomics
8.13.Laboratory Corporation of America Holdings
8.14.Tepnel Pharma Services,
8.15.BIOCRATES Life Sciences AG
Chapter 9 Europe Precision Market - Competitive Landscape
9.1.Market Share Analysis
9.2.Strategies Adopted by top companies
9.3.Mergers, Acquisitions, Collaborations & Agreements
Chapter 10 Market Insights
10.1. Industry Experts Insights
10.2.Analysts Opinions
10.3.Investment Opportunities
Chapter 11 Appendix
11.1 List of Tables
11.2 List of Figures
